Has Babak Arvanaghi, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,192 in general payments to Babak Arvanaghi, MD across 78 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Babak Arvanaghi, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Babak Arvanaghi, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Babak Arvanaghi, MD

Pain Medicine · Bethesda, MDNPI 1417963307

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 78 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 21.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $721 and has fallen 97.7% since, to $16 in 2025.

$2,192in general payments, 2019–2025

Across 78 payments — averaging $28.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Si-bone, Inc.$467
Medtronic$315
Collegium Pharmaceutical, Inc.$267
Abbott$246
Scilex Pharmaceuticals Inc.$224
Boston Scientific$166
plus $508 from 14 others

What the payments were for

Food & beverage$2,192100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Si-bone, Inc.	4	$467
Medtronic	5	$315
Collegium Pharmaceutical, Inc.	16	$267
Abbott	6	$246
Scilex Pharmaceuticals Inc.	12	$224
Boston Scientific	6	$166
Biodelivery Sciences International, Inc.	7	$90
Nevro Corp.	2	$63
Pfizer	3	$50
Pacira Pharmaceuticals Incorporated	2	$40
Pacira Therapeutics, Inc.	2	$39
Arbor Pharmaceuticals, Inc.	2	$36
AbbVie	2	$34
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	2	$30
SPR Therapeutics, Inc	1	$26
Lilly USA, LLC	2	$25
IBSA Pharma Inc.	1	$22
Vertex	1	$20
Sentynl Therapeutics, Inc.	1	$18
Stimwave Technologies Incorporated	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,192 in reported general payments places this provider in the 60th percentile of 144 pain medicine providers in Maryland.

See all pain medicine providers in Maryland →

Medicare billing

Part B allowed, 2024

$228,360

Medicare patients

573

Services billed

2,586

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
OxycontinOxycodone Hcl	23	$19,521
Lidocaine	32	$6,856
Gabapentin	118	$1,900
Pregabalin	36	$1,503
Oxycodone Hcl	55	$830
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	29	$779
Morphine Sulfate ErMorphine Sulfate	24	$500
Morphine Sulfate	18	$483
Tramadol Hcl	62	$474
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	30	$404
Tizanidine Hcl	29	$350
Hydromorphone Hcl	16	$312
Methadone Hcl	12	$266
Alprazolam	58	$66
Meloxicam	21	$31

Paid to pharmacies, not to this prescriber.

Other pain medicine in Bethesda

Ali TurabiBethesda$47K
Ankush JainBethesda$26K
Michael JacobsBethesda$11K
Edward DolomisiewiczBethesda$2K
Frank LeeBethesda$2K
Vipul MangalOxon Hill$764K
Randy DavisBaltimore$169K
Paul ChristoBaltimore$137K
Kunal SoodGermantown$70K
Behnam JafarpourBaltimore$45K

See the full list for Maryland →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →